Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Saber Soltani has a total of 169 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ACE Polymorphism and Clinical Outcomes in Iranian Patients with COVID-19

    by Saber Soltani, Alireza Tabibzadeh, Parastoo Yousefi, Abbas Farahani, Mojtaba Didehdar, Behnam Abedi, Sahar Khodashenas

    Background: The renin–angiotensin system may contribute to the pathogenesis of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A growing body of conflicting evidence suggests that the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism may be a risk factor for coronavirus disease 2019 (COVID-19). Objectives: This study aimed to evaluate the potential association between ACE I/D alleles and the severity of COVID-19 among Iranian patients. Methods: In this cross-sectional study, 80 patients with mild or severe COVID-19 and 20 healthy controls were evaluated for the ACE I/D polymorphism. Whole blood samples were used for DNA extraction, and the ACE I/D polymorphism was assessed using polymerase chain reaction, followed by electrophoresis on a 1% agarose gel. Results: The mean age of the patients was 54 ± 17 years, and 54 (67.5%) were men. Diabetes was the most common underlying disorder. Among the patients, 20 (25%) had the ACE II genotype, 47 (58.7%) had the ACE DI genotype, and 13 (16.2%) had the ACE DD genotype. No statistically significant association was observed between ACE alleles and COVID-19 severity (P > 0.05). Conclusions: No differences in ACE I/D allele frequencies were identified among patients with severe COVID-19, patients with mild COVID-19, and healthy controls. However, given the limited sample size and the lack of adjustment for potential confounders, this finding should be interpreted cautiously and does not rule out a true association.

  • Open Access

    Molecular Interplay Between COVID‐19 and Stroke: Experimental Insights Into MicroRNA‐Regulated Neuroinflammation

    by Saber Soltani, Milad Zandi, Habibollah Mirzaei, Saeedeh Ebrahimi, Hamid Reza Zaheri, Samaneh Abbasi

    Background: The recent COVID‐19 pandemic has resulted in a wide spectrum of neurological complications, including stroke, and emerging evidence suggests a critical role of microRNAs in their development. This study aimed to evaluate the expression levels of miR‐124, miR‐636, and miR‐485‐5p in COVID‐19 patients with and without stroke, compared with healthy individuals, to investigate their potential roles in COVID‐19‐associated neurological manifestations. Methods: This cross‐sectional study included 100 individuals: 25 COVID‐19 patients with stroke, 25 COVID‐19 patients without stroke, and 50 healthy controls. COVID‐19 infection was confirmed using RT‐PCR. Following plasma isolation and RNA extraction, quantitative real‐time PCR was performed to determine the expression levels of miR‐124, miR‐636, and miR‐485‐5p. The Kruskal–Wallis test followed by Dunn’s post hoc test was used for statistical analysis. Results: The miR‐124 expression was significantly increased in the stroke‐positive group (5.13 ± 2.48) compared to both the stroke‐negative (1.78 ± 1.03) and control groups (1.69 ± 0.64) ( p = 0.0084). Significant differences were observed between the stroke‐positive and stroke‐negative groups ( p = 0.0156), as well as between the stroke‐positive and control groups ( p = 0.0333). Although not statistically significant, a trend toward increased levels was observed in the stroke‐positive group ( p = 0.3594). miR‐636 showed no significant differences among the three groups ( p = 0.9987). miR‐485‐5p showed a nonsignificant trend toward higher levels in stroke‐positive patients (2.15 ± 1.53 vs. 1.38 ± 1.01, p = 0.36). Conclusion: The results demonstrated a significant overexpression of miR‐124 in COVID‐19 patients with stroke, highlighting its potential role in COVID‐19‐associated neurological disorders. Further studies are required to elucidate the underlying mechanisms and assess its potential as a diagnostic and therapeutic biomarker.

  • Leukemia-Related Signaling Pathways Among HTLV-1-Derived Adult T Cell Leukemia/Lymphoma and Asymptomatic Carriers in Comparison to Normal Group

    by Saber Soltani, Sayed-Hamidreza Mozhgani, Roozbeh Roohinezhad, Setareh Hedayati Emami, Mah Hedayati Emami, Setayesh Solooki, Mina Fattah Hesari, Niloofar Doroozeh, Mehdi Norouzi

    Human T-cell lymphotropic virus type 1 (HTLV-1) is associated with adult T-cell leukemia/lymphoma (ATLL), a fetal malignant infection. Recently, The HTLV-1 new Asymptomatic careers (ACs) have frequently been reported among blood donors. Reaching the profound concept of HTLV-1-associated molecular pathogenesis could result in finding novel therapeutic strategies. The current study aimed to determine leukemia-related signaling regulation in ATLL. 30 participants were evaluated in three groups, including 10 ATLL patients, 10 ACs, and 10 normal controls. Blood samples were isolated without any chemotherapy history from ATLL patients. Also, blood samples were recovered from ACs and normal individuals. Lymphocyte isolation was done on collected blood samples. After this, RNA was extracted from the prepared samples and utilized for the cDNA synthesis. Tax and HBZ as viral genes and cellular genes, including MKP-1, EVI-1, JNK-1, FOXO-1, AKT-1, DEPTOR, MTOR, and JUN, were investigated using real-time PCR. The mean age of ATLL patients was 53.2 ± 7.32 years, and 9 (90%) were male. The EVI-1 and FOXO-1 expression levels were significantly associated with ATLL patients compared to internal control. However, the significant differences in expression of other genes in the remaining groups were not seen. Discovering viral and cellular signaling pathways that regulate HTLV-1 transformation is essential. A novel therapeutic strategy for ATLL regulating cellular signaling pathways in vivo could be considered. Therefore, clinical trials using activators and inhibitors of related cellular signaling pathways for cell therapy of ATLL are recommended. It is recommended more investigation on FOXO-1 and EVI-1 for targeting these genes to reveal the molecular pathogenesis of ATLL.


  • Open Access

    Investigation of Epstein–Barr virus, Cytomegalovirus, Human herpesvirus 6, and Polyoma viruses (JC virus, BK virus) among Gastric cancer patients: A cross sectional study

    by Saber Soltani, Abbas Farahani, Ramin Shahbahrami, Zainab Shateri, Mohammad Saeid Emadi, Reza Pakzad, Maryam Lotfi, Behzad Asanjarani, Arezoo Rasti, Yousef Erfani, et al.

    Background and Aims: Gastric cancer is a significant global issue with a high death rate. This malignancy could be associated with several viral agents such as EBV, CMV, HHV‐6, JCV, and BKV.Objective: Evaluation of EBV, CMV, HHV‐6 ,and JCV, BKV frequency among gastric cancer patients.Methods: In this cross‐sectional study, a total number of 60 gastric cancer specimens (32 male, 28 female) were retrieved from the pathology lab. Formalin‐fixed paraffin‐embedded tissue was used for molecular testing. DNA was extracted from samples, according to protocol, and used for PCR reaction. Polymerase chain reactions were used to assess CMV, EBV, HHV‐6, JCV, and BKV frequency.Results and Conclusion: The mean age of the participants was 61 years and 53.3% (32) of the participants were Male. A total number of 5 samples (8.34%) were infected with viral agents. Four male gastric samples were infected with EBV (6.67%) and only one female sample contained the BKV genome (1.67%). Totally 8.34% of the samples were infected with EBV and BKV. The CMV, HHV‐6, and JCV genome was not detected in the samples. In conclusion, the presence of two viral agents including EBV and BKV among male and female samples respectively, and the genome of other viruses were not detected.


  • Open Access

    Exploring the Replication Mechanisms of DNA and RNA Viruses

    by Saber Soltani, Mohammad Shenagari, Mohammad Saeid Emadi

    This chapter provides an overview of the viral replication cycle, focusing on DNA and RNA viruses. The chapter begins with an introduction to viruses, their classification into DNA and RNA viruses, and their general characteristics. The process of DNA replication by viruses is then explained, including the different stages involved in this process and the specific mechanisms used by different types of DNA viruses. Similarly, the replication process of RNA viruses is discussed, with a focus on the various strategies employed by these viruses to replicate their genome. The purpose of this study is to investigate the intricate mechanisms involved in viral replication, which is essential for understanding the biology of viruses and developing strategies to control viral infections.


  • Open Access

    Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review

    by Parastoo Yousefi, Saber Soltani, Goli Siri, Sara Akhavan Rezayat, Ali Gholami, Alireza Zafarani, Mohamad Hossein Razizadeh, Ehsan Alborzi, Golnaz Mokhtary‐Irani, Behnam Abedi, et al.

    During 2019, the SARS‐CoV‐2 emerged from China, and during months, COVID‐19 spread in many countries around the world. The expanding data about pathogenesis of this virus could elucidate the exact mechanism by which COVID‐19 caused death in humans. One of the pathogenic mechanisms of this disease is coagulation. Coagulation disorders that affect both venous and arterial systems occur in patients with COVID‐19. The possible mechanism involved in the coagulation could be excessive inflammation induced by SARS‐CoV‐2. However, it is not yet clear well how SARS‐CoV‐2 promotes coagulopathy. However, some factors, such as pulmonary endothelial cell damage and some anticoagulant system disorders, are assumed to have an important role. In this study, we assessed conducted studies about COVID‐19‐induced coagulopathy to obtain clearer vision of the wide range of manifestations and possible pathogenesis mechanisms.


  • Open Access

    HSV-1 Infection Among COVID-19 Cases with Ocular and Neurological Manifestations

    by Saber Soltani, Mehrdokht Sadrkhanloo, Goli Siri, Amir Mohammad Zakeri, Mohammad Saeid Emadi, Alireza Tabibzadeh, Mojtaba Didehdar, Abbas Farahani

    Introduction: SARS-CoV-2 progression depends on multiple factors, including the compromised immune system and underlying diseases. HSV-1 reactivation in SARS-CoV-2 infection, more likely in patients with pneumonia and immunodeficiency, may be potentially life-threatening and implicate the prognosis. Case Presentation: We report two COVID-19 cases presenting ocular and neurological manifestations suspicious for HSV-1 encephalitis. Conclusions: Our study showed HSV-1 ocular manifestation among two COVID-19 cases. So, the recurrence of HSV-1 infection probably is related to immune responses during COVID-19 pathophysiology.

  • Open Access

    High Expression of Inflammatory Cytokines and Chemokines in Human T-lymphotropic Virus 1-Associated Adult T-cell Leukemia/Lymphoma

    by Saber Soltani, Sayed-Hamidreza Mozhgani, Goli Siri, Mohammad Saeid Emadi, Abbas Rahimi Foroushani, Seyed Mohammad Jazayeri, Atefeh Bahavar, Mehdi Norouzi

    Background: Human T-cell lymphotropic virus type 1 (HTLV-1) is the etiological agent of adult T-cell leukemia/lymphoma (ATLL) without any specific antiviral. Objectives: This study aimed to evaluate the expression level of inflammatory chemokines and pro-inflammatory cytokines in ATLL patients, asymptomatic carriers (ACs), and healthy individuals to assess the role of these inflammatory markers in ATLL pathogenicity. Methods: This study was conducted from May 2021 to August 2022. The ATLL blood samples were collected from the oncology wards of Imam Khomeini, Shariati, and Imam Hossein hospitals, in Tehran, Iran. The blood samples of ACs and normal control subjects were collected from blood donors referred to blood transfusion centers of Tehran and Alborz provinces, Iran. RNA extraction, complementary DNA (cDNA) synthesis, and real-time polymerase chain reaction (PCR) were done in targeted sample groups to investigate the correlation and expression rate of C-C motif chemokine ligand 3 (CCL3), C-C motif chemokine ligand 4 (CCL4), C-X-C motif chemokine ligand 8 (CXCL8), interleukin 23 subunit alpha (IL-23A), and interleukin 17 A (IL-17A). Results: A total of 30 samples were collected from 3 groups. The CCL3, CCL4, CXCL8, and IL-17A messenger RNA (mRNA) expression levels were significantly upregulated in the ATLL groups. There was a significant difference between CCL3 expression between the ACs and ATLL groups. In addition, CCL4 and CXCL8 expression levels were more significant in the ATLL group than in the normal control group. The IL-17A expression level significantly increased between groups. The IL-23A expression levels had no significant differences between the ATLL, ACs, and normal control groups. Conclusions: This study showed significant upregulation of pro-inflammatory cytokines and chemokines mRNAs in HTLV-1–associated ATLL compared to the ACs and normal control groups. Conducting more experiments to investigate the therapeutic effect of chemokines/cytokines in ATLL is essential.


  • Open Access

    Characterization of occult hepatitis B infection among Iranian liver transplant recipients

    by Azam Khamseh, Vahdat Poortahmasebi, Saber Soltani, Mohsen Nasiritoosi, Ali Jafarian, Azam Ghaziasadi, Mehdi Norouzi, Saied Ghorbani, Narges Eslami, Seyed Mohammad Jazayeri

    Background: The prevalence of occult hepatitis B infection (OBI) among Iranian liver transplant recipient patients has not been explored yet. The present study aimed to determine the OBI prevalence among Iranian liver transplant recipients. Methods: This study encompassed 97 patients having undergone liver transplantation due to several clinical backgrounds in the Liver Transplantation Center, Tehran, Iran. After serological evaluation, two different types of PCR methods were applied for amplification of HBV DNA, followed by the direct sequencing of whole hepatitis B virus (HBV) surface genes. Results: At the time of admission, none of the patients were positive for HBsAg. However, 24 (25%), 12 (12.3%), and 5 (5.1%) cases were positive for anti‐HBc, hepatitis C virus (HCV), and hepatitis delta virus (HDV) antibodies, respectively. Moreover, two males were positive for OBI (2.1%). Both were positive for anti‐HBc and negative for anti‐HBs, anti‐HCV, and anti‐HDV. HBV‐related cirrhosis was the underlying reason for their liver transplantation. HBsAg sequences revealed no amino acid substitution. Conclusions: The prevalence of OBI in the Iranian liver transplantation patients was relatively low. Future longitudinal studies with a larger sample size are suggested to explore the significance of this clinical finding, including the reactivation of cryptic HBV DNA, in liver transplant subjects.

  • Open Access

    Comment on Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. Pharmaceutics 2021, 13, 502

    by Milad Zandi, Saber Soltani

    In a published article in Pharmaceutics, researchers developed a sialic acid (SA) stabilized Au nanoparticle system based on SA’s binding ability that exists on the surface of lungs epithelial cells. The authors reported that many respiratory viruses including influenza, Middle-East respiratory syndrome (MERS-CoV), and the current coronavirus (SARS-CoV-2) bind to SA as one of the main binding targets of the surface protein hemagglutinin (HA).